Literature DB >> 12139924

Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells.

José M Vela1, Eduardo Molina-Holgado, Angel Arévalo-Martín, Guillermina Almazán, Carmen Guaza.   

Abstract

Interleukin-1 (IL-1) is a pleiotropic cytokine expressed during normal CNS development and in inflammatory demyelinating diseases, but remarkably little is known about its effect on oligodendroglial cells. In this study we explored the role of IL-1beta in oligodendrocyte progenitors and differentiated oligodendrocytes. The effects of IL-1beta were compared to those of IL-1 receptor antagonist, the specific inhibitor of IL-1 activity, since progenitors and differentiated oligodendrocytes produce IL-1beta and express IL-1 receptors. Unlike other proinflammatory cytokines (TNFalpha and IFNgamma), IL-1beta was not toxic for oligodendrocyte lineage cells. However, this cytokine inhibited proliferation of oligodendrocyte progenitors in the presence of growth factors (PDGF plus bFGF). This was evidenced by a significant decrease in both cells incorporating bromodeoxyuridine (45%) and total cell numbers (57%) after 6 days of treatment. Interestingly, IL-1beta blocked proliferation at the late progenitor/prooligodendrocyte (O4+) stage but did not affect proliferation of early progenitors (A2B5+). Inhibition of proliferation paralleled with promotion of differentiation, as revealed by the increased percentage of R-mab+ cells (6.7-fold). Moreover, when oligodendrocyte progenitors were allowed to differentiate in the absence of growth factors, treatment with IL-1beta promoted maturation to the MBP+ stage (4.2-fold) and survival of differentiating oligodendrocytes (2.1-fold). Regarding intracellular signaling, IL-1beta activated the p38 mitogen-activated protein kinase (MAPK) but not the p42/p44 MAPK and, when combined with growth factors, intensified p38 activation but inhibited the growth-factor-induced p42/p44 activation. IL-1beta also induced a time-dependent inhibition of PFGF-Ralpha gene expression. These results support a role for IL-1beta in promoting mitotic arrest and differentiation of oligodendrocyte progenitors as well as maturation and survival of differentiating oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139924     DOI: 10.1006/mcne.2002.1127

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  74 in total

1.  Post-transcriptional regulation of PDGFα-receptor in O-2A progenitor cells.

Authors:  Haiying Li; Chiayeng Wang
Journal:  Int J Clin Exp Med       Date:  2011-10-12

Review 2.  Inflammation processes in perinatal brain damage.

Authors:  Vincent Degos; Géraldine Favrais; Angela M Kaindl; Stéphane Peineau; Anne Marie Guerrot; Catherine Verney; Pierre Gressens
Journal:  J Neural Transm (Vienna)       Date:  2010-05-15       Impact factor: 3.575

Review 3.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 4.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

5.  Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.

Authors:  Aparna Patra; Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Yow-Pin Lim; James F Padbury; William A Banks; Barbara S Stonestreet
Journal:  Neuroscience       Date:  2017-01-09       Impact factor: 3.590

Review 6.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

Review 7.  Oligodendrocyte-microglia cross-talk in the central nervous system.

Authors:  Laura Peferoen; Markus Kipp; Paul van der Valk; Johannes M van Noort; Sandra Amor
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 8.  Immune influence on adult neural stem cell regulation and function.

Authors:  Pamela A Carpentier; Theo D Palmer
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

Review 9.  p38 Mitogen-activated protein kinase regulates myelination.

Authors:  Jeffery D Haines; Gabriela Fragoso; Shireen Hossain; Walter E Mushynski; Guillermina Almazan
Journal:  J Mol Neurosci       Date:  2007-11-10       Impact factor: 3.444

Review 10.  Inflammatory Biomarkers of Birth Asphyxia.

Authors:  Lina F Chalak
Journal:  Clin Perinatol       Date:  2016-09       Impact factor: 3.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.